Review paper

A Review of the Main Considerations for Formulation Development in Preclinical Toxicology Studies

Volume: 40, Issue: 6, Pages: 551 - 556
Published: Sep 13, 2021
Abstract
The main considerations for the development of a formulation for preclinical safety assessment testing are explored. Intravenous, inhalation, oral and dermal dosing are given focus and although different dose routes do present their own individual challenges there are common themes that emerge. In each case it is necessary to maximise exposure to achieve high doses to satisfy regulatory requirements for safety assessment testing. This often...
Paper Details
Title
A Review of the Main Considerations for Formulation Development in Preclinical Toxicology Studies
Published Date
Sep 13, 2021
Volume
40
Issue
6
Pages
551 - 556
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.